GeoVax Labs Inc.
Last updated September 27, 2026
Organization details
- Legal name
- GeoVax Labs Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- GOVX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0000832489
Board of directors
-
David A. Dodd · Director · President, CEOSince 2023
-
Dean G. Kollintzas · DirectorSince 2023
-
Jayne Morgan · DirectorSince 2023
-
John N. Spencer Jr. · DirectorSince 2023
-
Nicole Lemerond · DirectorSince 2023
-
Randal D. Chase · DirectorSince 2023
-
Robert T. Mcnally · DirectorSince 2023
Chief executives
David A. Dodd
· President, CEO
Dates unknown
Board connections
1 of this board's directors also sit on 2 other boards.
- via Nicole Lemerond
- via Nicole Lemerond
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $5,500
- 1 purchase by 1 insider
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 17, 2025 | John N. Spencer Jr. Director | Open-market purchase | +10,000 | $0.55 | $5,500 |
| Aug 7, 2025 | McKee Kelly T. Jr. Officer (Chief Medical Officer) | Open-market purchase | +1,107 | $0.67 | $742 |
| Apr 10, 2025 | John N. Spencer Jr. Director | Open-market purchase | +10,000 | $0.98 | $9,800 |
| Apr 10, 2025 | Sharkey John W. Officer (VP, Business Development) | Open-market purchase | +6,000 | $0.99 | $5,940 |
| Apr 1, 2025 | David A. Dodd Director, Officer (President, CEO) | Open-market purchase | +10,000 | $1.08 | $10,800 |
| Mar 31, 2025 | Reynolds Mark Officer (CFO) | Open-market purchase | +6,800 | $1.08 | $7,344 |
| Aug 9, 2024 | David A. Dodd Director, Officer (President, CEO) | Open-market purchase | +8,000 | $1.95 | $15,600 |
| Feb 22, 2024 | David A. Dodd Director, Officer (President, CEO) | Open-market purchase | +8,209 | $2.27 | $18,634 |
| Feb 21, 2024 | David A. Dodd Director, Officer (President, CEO) | Open-market purchase | +520 | $2.15 | $1,118 |
| Feb 7, 2024 | Reynolds Mark Officer (CFO) | Open-market purchase | +2,000 | $2.77 | $5,540 |
| Dec 22, 2023 | McKee Kelly T. Jr. Officer (Chief Medical Officer) | Open-market purchase | +6,944 | $0.36 | $2,500 |
| Sep 25, 2023 | McKee Kelly T. Jr. Officer (Chief Medical Officer) | Open-market purchase | +9,653 | $0.52 | $5,020 |
| Aug 25, 2023 | David A. Dodd Director, Officer (President, CEO) | Open-market purchase | +35,087 | $0.57 | $20,000 |
| Aug 18, 2023 | Reynolds Mark Officer (CFO) | Open-market purchase | +10,000 | $0.52 | $5,200 |
| Apr 24, 2023 | David A. Dodd Director, Officer (President, CEO) | Open-market purchase | +32,000 | $0.64 | $20,480 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.